|
|
|
 |
FDA Approval Activities for this Drug…
Tigan (Trimethobenzamide Hydrochloride) Suppositories, Injection, King NDA 17-529/S-009, 17-530/S-018 4/30/02 5/2/02 5/24/02 Tigan (Trimethobenzamide Hydrochloride) Capsules, King NDA 17-531/S-010 4/30/02 1/13/03 1/13/03 Tigan (Trimethobenzamide Hydrochloride) Capsules, 300 mg, King NDA 17-531 Trimethobenzamide Hydrochloride Capsules, 300mg Mutual Pharmaceutical ANDA 76-570 8/28/03 Trimethobenzamide Hydrochloride Capsules, 300mg Amide ANDA 76-546 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TRIMETHOBENZAMIDE HCL Amide 017531 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TIGAN KING 076570 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TRIMETHOBENZAMIDE HCL Mutual 088804 TRIMETHOBENZAMIDE HYDROCHLORIDE Injection 100MG/ML TRIMETHOBENZAMIDE HCL Abbott 017530 TRIMETHOBENZAMIDE HYDROCHLORIDE Injection 100MG/ML TIGAN KING | Tigan (trimethobenzamide hydrochloride) Injection, King Pharma, Formulation Revision, Package Change & Manufacturing Change or Addition | Tigan (trimethobenzamide hydrochloride) Capsules, King Pharma, Labeling Revision | Tigan (trimethobenzamide hydrochloride) Intramuscular Injection, JHP Pharma, Labeling Revision | Tigan (trimethobenzamide hydrochloride), Capsules, King Pharmaceuticals, Inc., Labeling Revision | Trimethobenzamide Hydrochloride Injection, PharmaForce Inc., Approval
  
|